Bulletin
Investor Alert

Intra-Cellular Therapies Inc.

NAS: ITCI

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Intra-Cellular Therapies Inc.

After Hours

ITCI
/zigman2/quotes/209441868/composite

$

48.39

Change

-1.35 -2.71%

Volume

Volume 53,278

Feb 2, 2023, 7:47 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209441868/composite

Today's close

$ 47.82

$ 49.74

Change

+1.92 +4.02%

Day low

Day high

$47.09

$49.78

Open
Open: 47.85

52 week low

52 week high

$42.42

$66.00

Open

Market cap

$4.53B

Average volume

547,642

P/E ratio

N/A

Rev. per Employee

$367,414

EPS

-3.32

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/itci

MarketWatch News on ITCI

  1. Thematic ETFs Look Tempting. Just Say No.

    4:01 p.m. Dec. 12, 2022

    - Barron's Online

  2. Intra-Cellular Therapies started at buy with $74 stock price target at Mizuho

    6:06 a.m. July 7, 2022

    - Tomi Kilgore

  3. Intra-Cellular Therapies started at buy with $75 stock price target at UBS

    9:52 a.m. June 14, 2022

    - Tomi Kilgore

  5. The FDA Is About to Make Some Major Drug Decisions

    1:51 p.m. Oct. 16, 2021

    - Barron's Online

  7. Intra-Cellular Therapies downgraded to neutral from overweight at J.P. Morgan

    7:54 a.m. Jan. 31, 2020

    - Tomi Kilgore

  8. Intra-Cellular Therapies stock price target raised to $65 vs. $29 at Canaccord

    10:48 a.m. Dec. 24, 2019

    - Ciara Linnane

  9. Intra-Cellular Therapies reiterated as buy at Canaccord

    10:48 a.m. Dec. 24, 2019

    - Ciara Linnane

  12. Intra-Cellular Therapies gets FDA approval for schizophrenia treatment

    7:14 a.m. Dec. 23, 2019

    - Ciara Linnane

  13. Intra-Cellular Therapies stock soars 42% premarket

    7:14 a.m. Dec. 23, 2019

    - Ciara Linnane

  15. Intra-Cellular Therapies shares slide 7% after resuming trade following halt.

    6:36 a.m. July 8, 2019

    - Ciara Linnane

  17. Intra-Cellular announces positive results in late-stage trial of treatment for bipolar depression

    6:05 a.m. July 8, 2019

    - Ciara Linnane

  18. Intra-Cellular Therapies and Sol-Gel Technologies halted for news pending

    5:58 a.m. July 8, 2019

    - Ciara Linnane

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/itci

Other News on ITCI

  4. Top 5 3rd Quarter Trades of GW&K Investment Management, LLC

    2:00 p.m. Nov. 9, 2022

    - GuruFocus.com

  12. Intra-Cellular Therapies Q3 2022 Earnings Preview

    12:39 p.m. Nov. 2, 2022

    - Seeking Alpha

  13. Lisanti Capital Growth, LLC Buys 2, Sells 3 in 3rd Quarter

    8:00 a.m. Nov. 2, 2022

    - GuruFocus.com

  17. Intra-Cellular Therapies: What Lies Ahead

    6:45 p.m. Sept. 20, 2022

    - Seeking Alpha

  18. Axsome: In The Middle Of Uncertainty Is Your Biggest Opportunity

    12:31 p.m. Sept. 16, 2022

    - Seeking Alpha

  19. Warning: ITCI is at high risk of performing badly

    3:51 a.m. Sept. 9, 2022

    - Seeking Alpha

  20. Warning: ITCI is at high risk of performing badly

    1:50 a.m. Aug. 31, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/itci

Press Releases on ITCI

  12. What Stocks To Buy This Week? 4 Biotech Stocks To Know

    10:20 a.m. May 15, 2022

    - StockMarket.com

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.